Skip to main content
. 2021 Mar 15;12:510350. doi: 10.3389/fgene.2021.510350

Table 2.

Genotype frequency distribution of MRP4 in KD cases.

Genotype IVIG-R
(n = 148)
IVIG-S
(n = 612)
pa OR (95% CI) p Adjusted OR (95% CI) Adjusted pb
rs1751034 T/C
TT 82 (55.41) 387 (63.24) 0.0441 1.00 1.00
TC 54 (36.49) 203 (33.17) 1.26 (0.86–1.84) 0.2446 1.26 (0.86–1.84) 0.2427
CC 12 (8.11) 22 (3.59) 2.57 (1.23–5.41) 0.0126 2.54 (1.21–5.34) 0.0143
Dominant 66 (44.59) 225 (36.76) 0.0807 1.38 (0.96–1.99) 0.0793 1.38 (0.96–1.99) 0.0803
Recessive 136 (91.89) 590 (96.41) 0.0268 2.37 (1.14–4.90) 0.0203 2.33 (1.12–4.83) 0.0230
rs3742106 A/C
AA 30 (20.27) 139 (22.71) 0.4010 1.00 1.00
AC 80 (54.05) 293 (47.88) 1.27 (0.79–2.02) 0.3223 1.27 (0.80–2.02) 0.3190
CC 38 (25.68) 180 (29.41) 0.98 (0.58–1.66) 0.9346 0.97 (0.57–1.65) 0.9215
Dominant 118 (79.73) 473 (77.29) 0.5179 1.16 (0.74–1.80) 0.5217 1.16 (0.74–1.80) 0.5236
Recessive 110 (74.32) 432 (70.59) 0.3631 0.83 (0.55–1.25) 0.3676 0.83 (0.55–1.24) 0.3551
rs9561778 G/T
GG 70 (47.30) 307 (50.16) 0.8199 1.00 1.00
GT 67 (45.27) 261 (42.65) 1.13 (0.78–1.64) 0.5339 1.12 (0.77–1.63) 0.5494
TT 11 (7.43) 44 (7.19) 1.10 (0.54–2.23) 0.7994 1.08 (0.53–2.20) 0.8301
Dominant 78 (47.30) 307 (50.16) 0.5313 1.12 (0.78–1.61) 0.5316 1.11 (0.78–1.60) 0.5529
Recessive 137 (92.57) 568 (92.81) 0.9187 1.04 (0.52–2.06) 0.9177 1.02 (0.51–2.04) 0.9478
rs3765534 C/T
CC 131 (88.51) 556 (90.85) 0.4931 1.00 1.00
CT 16 (10.81) 55 (8.99) 1.24 (0.69–2.22) 0.4825 1.26 (0.70–2.28) 0.4398
TT 1 (0.68) 1 (0.16) 4.24 (0.26–68.30) 0.3078 4.64 (0.29–75.21) 0.2801
Dominant 17 (11.49) 56 (9.15) 0.3964 1.29 (0.73–2.29) 0.3877 1.32 (0.74–2.35) 0.3488
Recessive 147 (99.32) 611 (99.84) 0.3333 4.16 (0.26–66.84) 0.3148 4.51 (0.28–72.97) 0.2892
rs868853 T/C
TT 107 (72.30) 417 (68.14) 0.6126 1.00 1.00
TC 38 (25.68) 181 (29.58) 0.82 (0.54–1.23) 0.3365 0.82 (0.55–1.24) 0.3486
CC 3 (2.03) 14 (2.29) 0.84 (0.24–2.96) 0.7801 0.82 (0.23–2.91) 0.7571
Dominant 41 (27.70) 195 (31.86) 0.3224 0.82 (0.55–1.22) 0.3269 0.82 (0.55–1.22) 0.3345
Recessive 145 (97.97) 598 (97.71) 0.8456 0.88 (0.25–3.12) 0.8476 0.87 (0.25–3.05) 0.8213
rs7320375 A/G
AA 97 (65.54) 382 (62.42) 0.5861 1.00 1.00
AG 43 (29.05) 203 (33.17) 0.83 (0.56–1.24) 0.3713 0.84 (0.56–1.25) 0.3840
GG 8 (5.41) 27 (4.41) 1.17 (0.51–2.65) 0.7121 1.18 (0.52–2.67) 0.7004
Dominant 51 (34.46) 230 (37.58) 0.4785 0.87 (0.60–1.27) 0.4803 0.88 (0.60–1.28) 0.4959
Recessive 140 (94.59) 585 (95.59) 0.6118 1.24 (0.55–2.78) 0.6053 1.25 (0.55–2.81) 0.5949
Combined effect of risk genotypes
0–2 84 (56.76) 409 (66.83) 0.0227 1.00 1.00
3–6 64 (43.24) 203 (33.17) 1.52 (1.05–2.22) 0.0283 1.52 (1.04–2.22) 0.0295
a

Two-sided χ2 test for distributions between Kawasaki disease patients with IVIG resistance and IVIG sensitivity.

b

Adjusted for age and gender status in logistic regress models.

Bold values indicate value of p less than 0.05.